• Decrease font size
  • Reset font size to default
  • Increase font size
Home About Us Executive Committee Raymond O. Estacio, MD - Peer Reviewed Journal Articles

Raymond O. Estacio, MD - Peer Reviewed Journal Articles

  1. Mori J Krantz, William A Baker, Raymond O Estacio, Debra K Haynes, Philip S Mehler, GC Fonarow, Carlin S Long.Comprehensive coronary artery disease care in a safety-net hospital: results of get with the guidelines quality improvement initiative.J Manag Care Pharm. 2007;13(4):319-24.
  2. Bernhane Seyoum, Raymond O Estacio, Paulos Berhanu and Robert W Schrier. Exercise capacity is a predictor of cardiovascular events in patients with type 2 diabetes mellitus. Diab Vasc Dis Res. 2006, 3(3):197-201.
  3. Raymond O Estacio, Joseph Coll, Zung Vu Tran and Robert W Schrier. Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes. Am J Hypertens. 2006, 19(12):1241-8.
  4. Carl Bartecchi, Robert N. Alsever, Catherine Nevin-Woods, William M. Thomas, Raymond O. Estacio, Becki B. Bartelson, and Mori J. Krantz, Reduction in the incidence of acute myocardial infarction associated with a citywide smoking ordinance, Circulation, 2006, 114: 1490-1496.
  5. M. Kamgar, N. Nobakhthaghighi, A. A. Shamshirsaz, R. O. Estacio, K. K. McFann, and R. W. Schrier, Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease, Kidney Int., 2006, 69 : 1899-1903.
  6. Philip S Mehler, Mori J Krantz, Rita A Lundgren, Raymond O. Estacio, Thomas D MacKenzie, Laurel Petralia, William R Hiatt. Bridging the quality gap in diabetic hyperlipidemia: a practice-based intervention. Am J Med. 2005: 118(12):1414.
  7. Mori J. Krantz, Raymond O. Estacio, Phillip S. Mehler. Angiotensin Converting Enzyme Inhibitors and myocardial infarction: a class effect? Am J Cardiol 2005;95(7):924.
  8. Chirag R. Parikh, Michael J. Fischer, Raymond O. Estacio, Robert W. Schrier. Rapid microalbuminuria screening in type 2 diabetes mellitus: simplified approach with Micral test strips and specific gravity. Nephrol Dial Transplant 2004; 19(7):1881-1885, 2004.
  9. Melinda L. Hockensmith, Raymond O. Estacio, Philip S. Mehler, Edward P. Havranek, S. Tevfik Ecder, Rita A. Lundgren, Robert W. Schrier. Albuminuria a a predictor of heart failure hospitalizations in patients with type 2 diabetes. J of Cardiac Fail, 10(2) 126 – 131, 2004.
  10. Jefferey A. Cohen, Raymond O. Estacio, Rita A. Lundgren, Anne L. Esler, Robert W. Schrier. Diabetic autonomic neuropathy is associated with an increased incidence of strokes. Auton Neurosci, 108(1-2):73-78, 2003.
  11. Ricardo Padilla, Raymond O. Estacio. New Insights into the Combined Burden of Type 2 Diabetes and Hypertension. HeartDrug, 3: 25-33, 2003.
  12. Edward P Havranek, Anne Esler, Raymond O Estacio, Philip S Mehler and Robert W Schrier. Differential effects of anti-hypertensive agents on ECG voltage: results for the Appropriate Blood Pressure Control in Diabetes (ABCD) Trial. Am Heart J, 145(6):993-8, 2003.
  13. Philip S. Mehler, Joseph R. Coll, Raymond O Estacio, Anne Esler, Robert W. Schrier, William R. Hiatt. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation, 107(5):753-6, 2003.
  14. Philip S. Mehler, Anne Esler, Raymond O Estacio, Thomas D MacKenzie, William R. Hiatt and Robert W. Schrier. Lack of improvement in the treatment of hyperlipidemia among patients with type 2 diabetes. Am J Medicine, 114(5):377-82, 2003.
  15. Robert W. Schrier, Raymond O. Estacio, Anne Esler, and Philip Mehler. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney International, 61, 1086 - 97, 2002.
  16. Raymond O. Estacio. Treatment of high-risk diabetic patients with ARBs. Diabetes, Obesity and Metabolism, 3: 472-6, 2001. Jeffrey A. Cohen, Barrett W. Jeffers, Sally Stabler, Raymond Estacio, and Robert W. Schrier. Increasing homocysteine levels and diabetic autonomic neuropathy. Auton Neurosci., 23;87(2-3):268-73, 2001
  17. Raymond O. Estacio, Barrett W. Jeffers, Stacy L. Biggerstaff, Nancy Gifford, and Robert W. Schrier. The effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 23 Suppl 2:B54-64, 2000.
  18. Sally P. Stabler, Raymond Estacio, Barrett W. Jeffers, Jeffrey A. Cohen, Robert H. Allen and Robert W. Schrier. Total homocysteine is associated with nephropathy in non-insulin-dependent diabetes mellitus. Metabolism, 48(9): 1096-101, 1999
  19. Raymond O. Estacio, Edward P Havranek, Barrett W. Jeffers, Olga Samsen, David Krick and Robert W. Schrier. Angiotensin converting enzyme gene polymorphism and left ventricular hypertrophy in NIDDM. American Journal of Hypertension, 12(6): 637-642, 1999
  20. Raymond O. Estacio, Eric McFarling, Stacy Biggerstaff, Barrett W. Jeffers, David Johnson and Robert W. Schrier. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. American Journal of Kidney Diseases, 31(6): 947-953, 1998.
  21. Raymond O. Estacio, Barrett W. Jeffers, William H. Hiatt, Stacy L Biggerstaff, Nancy Gifford and Robert W. Schrier. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med, 338(10): 645-652, 1998.
  22. Raymond O. Estacio, Barrett W. Jeffers, Judith Regensteiner, Matthew Dickenson, Eugene E. Wolfel and Robert W. Schrier. The association between diabetic complications and exercise capacity in NIDDM. Diabetes Care, 21(2): 291-295, 1998.
  23. Barrett W. Jeffers, Raymond O. Estacio, Mary V. Raynolds and Robert W. Schrier. Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney International, 52: 473-477, 1997.
  24. Susan Savage, Raymond O. Estacio, Barrett W. Jeffers and Robert W. Schrier. Glycemic control and complications in non-insulin dependent diabetic (NIDDM) patients treated with insulin versus oral hypoglycemic agents: population study. Proc Assoc Am Phys, 109(2): 181-189, 1997.
  25. Phillip Mehler, Barrett W. Jeffers, Raymond O. Estacio and Robert W. Schrier. Association of hypertension and complications in non insulin-dependent diabetes mellitus. Am J Hypertension, 10: 152-161, 1997.
  26. Robert W. Schrier, Raymond O Estacio and Barrett W. Jeffers. Appropriate Blood Pressure Control in NIDDM (ABCD) Trial. Diabetologia, 39: 1646-1654, 1996.
  27. Susan Savage, Raymond O. Estacio, Barrett W. Jeffers and Robert W. Schrier. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM, Diabetes Care, 19(11): 1243-1248, 1996.
  28. Raymond O. Estacio, Eugene E. Wolfel, Judith G. Regensteiner, Barrett W. Jeffers, Edward P. Havranek, Susan Savage and Robert W. Schrier. Effect of risk factors on exercise capacity in non insulin-dependent diabetes mellitus (NIDDM). Diabetes 45: 79-85, 1996.
  29. Raymond O. Estacio, Susan Savage, Nancy Johnson Nagel and Robert W. Schrier. Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes Trial. Controlled Clinical Trials 17: 242-257, 1996.
  30. Susan Savage, Nancy Johnson Nagel, Raymond O. Estacio, Nancy Lukken and Robert W. Schrier. Clinical factors associated with urinary albumin excretion in type II diabetes. American Journal of Kidney Diseases 25(6): 836-844, 1995.
  31. Susan Savage, Nancy L. Johnson, Raymond O. Estacio, Peter U. Feig, E. Paul MacCarthy, Nancy J. Lukken, Reiner Ziegler and Robert W. Schrier. The ABCD (Appropriate Blood Pressure Control in Diabetes) Trial: Rationale and Design of a Trial of Hypertension Control (Moderate or Intensive) in Type II Diabetes. Online Journal of Current Clinical Trials Doc No. 104, 1993.

< TOP >

Non-Peer Reviewed:
  1. Raymond O. Estacio and Robert W. Schrier. Chapter on Hypertension and Diabetes in Diseases of the Kidney and Urinary Tract. Editor: Robert W. Schrier, 2006.
  2. Raymond O. Estacio and Robert W. Schrier. Chapter on Hypertension and Diabetes in Diseases of the Kidney and Urinary Tract. Editor: Robert W. Schrier, 2001.
  3. Robert W. Schrier and Raymond O. Estacio. The effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a pooled analysis of individual-patient data from 11 randomized, controlled trials. Ann Intern Med. 135(2):138-9, editorial, 2001.
  4. Philip S. Mehler and Raymond Estacio. Smoking and abnormalities in renal function. Ann Intern Med. 2001 Jul 3;135(1):67.
  5. Raymond O. Estacio, Robert W. Schrier. Diabetic nephropathy: pathogenesis and treatment. Advances in Internal Medicine, 45: 359 - 408, 2001.
  6. Robert W. Schrier and Raymond O Estacio. Additional follow-up from the ABCD trial in patients with type 2 diabetes and hypertension N Eng J Med. 343 (26): 1969, 2000.
  7. Raymond O. Estacio, Philip Mehler and Robert Schrier: Chapter on Prevalence and predictors of nephropathy in patients with type 2 diabetes, nephropathy in type 2 diabetes. Editors Eberhard Ritz and Ivan Rychlik, 1999.
  8. Raymond O. Estacio, Robert Eckel: Chapter on Abnormalities in Lipids, Primary Care Secrets. Second Edition Editor, Jeanette Mladenovic, M.D., 1999.
  9. Raymond O. Estacio. Diabetic microalbuminuria: management and prognostic significance. Primary Care Case Reviews, 2(3): 125-132, 1999.
  10. Raymond O. Estacio and Robert W. Schrier. Antihypertensive therapy in type 2 diabetes: implications of the Appropriate Blood Pressure Control in Diabetes Trial. American Journal of Cardiology, Am J Cardiol, 82: 9R-14R, 1998.
  11. Robert W. Schrier and Raymond O. Estacio. Clinical correlates with microalbuminuria in non-insulin dependent diabetes: Preliminary results of the Appropriate Blood Pressure Control in Diabetes trial. Nephrology, 2:51-54, 1996.
  12. Raymond O. Estacio, Robert Eckel: Chapter on Abnormalities in Lipids, Primary Care Secrets. Editor, Jeanette Mladenovic, M.D., 1994.

< Top >

Abstracts:

  1. Henry Fischer, Thomas MacKenzie, Raymond O. Estacio. Nurse administered telephonic cholesterol outcomes study. Society of Gen Int Med, Los Angeles, CA May 2006.
  2. Edward P. Havranek, Caroline Bublitz, Frederick A. Masoudi, Mori J. Krantz, Rebecca Hanratty,
  3. Raymond O. Estacio, Miriam Dickinson, and John F. Steiner. Defining a Threshold in the Relationship between Mortality and Electrocardiographic Indices of Left Ventricular Hypertrophy. American College of Cardiology Annual Scientific Session, Atlanta, GA, March 2006
  4. Carl Bartecchi, Nick Alsever, Chris Nevin-Woods, William Thomas, Raymond Estacio, Becki Bucher Bartelson, Mori Krantz. A City-wide Smoking Ordinance Reduces the Incidence of Acute Myocardial Infarction. American Heart Association, Dallas, TX, November 2005.
  5. Raymond O Estacio, Anne L Esler, Rita A Lundgren and Robert W Schrier. Intensive Blood Pressure Control With Valsartan Decreases Progression Of Urinary Albumin Excretion In Normotensive Type 2 Diabetic Patients: Appropriate Blood Pressure Control in Diabetes Part 2 with Valsartan (ABCD-2V) Trial. American Society of Hypertension, New York, May 2004
  6. Rita A. Lundgren, Anne L. Esler, Raymond O. Estacio, Robert W. Schrier. Planning the statistical analysis of a clinical trial when recruitment goals are not met. SCT, London, July 2003
  7. Julie Entwisle, Thomas D. MacKenzie, Philip Mehler, Alicia Wolfert, Stanely Soria, Raymond O. Estacio, Protocol driven, nurse run hypertension clinic, J Gen Int Med., 18(Suppl): 131, 2003.
  8. Karen M. Chacko, James A. Dixon, Timothy A. Bauer, Rita A. Lundgren, Raymond O. Estacio. Heart Rate Recovery as a Predictor of Cardiac and All-Cause Mortality Among Patients with Type 2 Diabetes Mellitus. J Gen Int Med. 2003;18(Supp1):142, 2003.
  9. Jeffrey A. Cohen, Raymond O. Estacio, Rita Lundgren, Anne Esler, and Robert W. Schrier. Diabetic Autonomic Neuropathy and Microvascular Complications are Independently Associated with Impotency in Type 2 Diabetes. American Assoc of Neurology, Denver, April 2002.
  10. Chirag R. Parikh, Raymond Estacio, Robert W. Schrier. Performance of Micral Urine Test Strip for Microalbuminuria in Type II Diabetics. World Congress of Nephrology Meeting, San Francisco, October 2001.
  11. Melinda L. Hockensmith, Raymond O. Estacio, Philip S. Mehler, Edward P. Havranek, S. Tevfik Ecder, Rita A. Lundgren, Robert W. Schrier Albuminuria Predicts the Onset of Congestive Heart Failure in Type 2 Diabetes Mellitus. World Congress of Nephrology Meeting, San Francisco, October 2001.
  12. Raymond O. Estacio, Robert W. Schrier, Anne Esler, and Philip Mehler. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. World Congress of Nephrology Meeting, San Francisco, October 2001.
  13. Berhane Seyoum, Raymond O. Estacio, Paulos Berhanu, and Robert W. Schrier.Exercise Capacity as a predictor of cardiovascular disease events. American Diabetes Association Meeting. June 2001.
  14. Jeffrey A. Cohen, Raymond Estacio, Rita Lundgren and Robert W. Schrier. Diabetic Autonomic Neuropathy as a Predictor of Strokes. AAN, Philadelphia, May 2001.
  15. Colin D. Shafer; Raymond O. Estacio, Barrett W. Jeffers, Edward P. Havranek and Robert W. Schrier. Microvascular Complications of Type 2 Diabetes as Predictors of Increased Left Ventricular Mass. SGIM Meeting, Boston, Massachusetts, May 2000.
  16. Berhane Seyoum, Paulos Berhanu, Raymond O. Estacio, Mary Raynolds, Anne Esler, Robert W. Schrier. Association of Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism with Myocardial Infarction in Patients with Type 2 Diabetes Mellitus. American Diabetes Association Conference, San Antonio, Texas, June 2000
  17. Raymond O. Estacio, Barrett W. Jeffers, Stacy Biggerstaff, Nancy Gifford and Robert W. Schrier. Effects of a Calcium Channel Antagonist versus an ACE Inhibitor on Diabetic Nephropathy, American Society of Nephroplogy, Philadelphia, PA, October 1998.
  18. Raymond O. Estacio, Edward P Havranek, Barrett W. Jeffers, Olga Samsen, David Krick and Robert W. Schrier. Deletion Polymorphsm of the Angiotenisn-Converting Enzyme (ACE) Gene is Associated with an Increase in Left Ventricular Mass in Males with NIDDM. American Diabetes Association, Boston, June 1997.
  19. Barrett W. Jeffers, Raymond O. Estacio and Robert W. Schrier. The Relationship Between Diabetic Complications and Angiotensin-Converting Enzyme Polymorphism in Non-Insulin-Dependent Diabetes Mellitus. American Diabetes Association, San Francisco, June 1996.
  20. Eric McFarling, Barrett W. Jeffers, Raymond O. Estacio and Robert W. Schrier. Diabetic Retinopathy in Hispanics and Non-Hispanic Whites With Non-Insulin-Dependent Diabetes Mellitus. American Diabetes Association, San Francisco, June 1996.
  21. Charles Fuenzalida, Edward Havranek, Susan Savage, Raymond O. Estacio, Koonlawee Nademanee and Robert W. Schrier. ABCD Trial: Increased Left Ventricular Mass and Correlation with Risk Factors in Type II Diabetes Mellitus. American Diabetes Association, New Orleans, June 1994.
  22. Susan Savage, Nancy Johnson Nagel, Raymond O. Estacio, Nancy Lukken and Robert Schrier. Factors Associated with Urinary Albumin Excretion in Type II Diabetes Mellitus. American Federation of Clinical Research, Baltimore, April 1994.
  23. Susan Savage, Nancy Johnson Nagel, Raymond O. Estacio, Nancy Lukken and Robert W. Schrier. ABCD Trial: Insulin Therapy in Type II Diabetes - Correlation with Glycemic Control. American Federation of Clinical Research, Carmel California, February 1994.
  24. Susan Savage, Nancy Johnson Nagel, Raymond O. Estacio, Nancy Lukken and Robert W. Schrier. Correlates of Hyperfiltration in Type II Diabetes Mellitus. American Society of Nephrology. Boston, November 1993.

< TOP >